Analysis of short-term efficacy and safety of mitoxantrone hydrochloride liposome regimen therapy in adult acute myeloid leukemia

作者全名："Ma, Jun; Hu, Junbin; Liu, Li; Chen, Yuqing; He, Aili; Lou, Shifeng; Ge, Jian; Qi, Kunming; Yang, Yanli; Ye, Jingjing; Cheng, Hai; Lu, Yinghao; Wang, Linhui; Cai, Huili; Wei, Xudong; Yang, Xiangdong; Xue, Hua; Wang, Hongxiang"

作者地址："Harbin Inst Hematol & Oncol, Dept Hematol & Oncol, Harbin, Peoples R China; Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; Tangdu Hosp, Xian, Peoples R China; Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China; Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; XuZhou Med Univ, Affiliated Hosp, Xuzhou, Peoples R China; Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China; Shandong Univ, Qilu Hosp, Jinan, Peoples R China; Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China; Guizhou Prov Peoples Hosp, Guiyang, Peoples R China; Yichang Cent Peoples Hosp, Yichang, Peoples R China; Henan Canc Hosp, Zhengzhou, Peoples R China; Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China; Hebei Univ, Affiliated Hosp, Baoding, Peoples R China; Cent Hosp Wuhan, Wuhan, Peoples R China"

通信作者：　

来源：JOURNAL OF CLINICAL ONCOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001053772003411

JCR分区：Q1

影响因子：42.1

年份：2023

卷号：41

期号：16

开始页：　

结束页：　

文献类型：Meeting Abstract

关键词：　

摘要：　

基金机构："CSPC Ouyi Pharmaceutical Co., Ltd."

基金资助正文："CSPC Ouyi Pharmaceutical Co., Ltd."